title: Atypical linear toxicodermia by sorafenib.
authors.forename: María
authors.initials: M
authors.lastname: Rodríguez-Vázquez
authors.forename: María Luisa
authors.initials: ML
authors.lastname: Martinez-Martínez
authors.forename: Mónica
authors.initials: M
authors.lastname: García-Arpa
authors.forename: Luis Iñiguez
authors.initials: LI
authors.lastname: De Onzoño
mesh_terms: D000328:Adult; D001557:Benzenesulfonates / Q000008:administration & dosage / Q000009:adverse effects*; D001706:Biopsy; D004487:Edema / Q000139:chemically induced; D005260:Female; D006527:Hepatolenticular Degeneration / Q000188:drug therapy; D006801:Humans; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects*; D012867:Skin / Q000473:pathology; D017444:Skin Diseases, Papulosquamous / Q000139:chemically induced*; D000077157:Sorafenib
chemical_list: D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib